Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
XORTX Therapeutics Inc. (XRTX) had Free Cash Flow per Share of $-0.54 for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-3.02M |
|
-- |
|
-- |
|
$1.09M |
|
$-1.09M |
|
$-1.93M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-1.09M |
|
$-1.07M |
|
2.43M |
|
2.43M |
|
$-1.24 |
|
$-1.24 |
|
| Balance Sheet Financials | |
$4.66M |
|
$0.02M |
|
$1.39M |
|
$6.05M |
|
$0.34M |
|
-- |
|
$3.22M |
|
$3.56M |
|
$2.49M |
|
$2.33M |
|
$2.49M |
|
2.90M |
|
| Cash Flow Statement Financials | |
$-1.30M |
|
$-0.00M |
|
$1.70M |
|
$3.45M |
|
$3.84M |
|
$0.39M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.68 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-121.19% |
|
-129.84% |
|
-49.89% |
|
-121.19% |
|
$0.86 |
|
|
Free Cash Flow per Share |
$-0.54 |
$-0.54 |
|